NCT07393529

Brief Summary

This is a pilot randomized controlled trial to assess the feasibility, acceptability, appropriateness, and structure of the SONATA intervention. In addition, it will assess the preliminary efficacy of SONATA compared to enhanced usual care among 70 older adults with advanced cancer.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
34mo left

Started Apr 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Apr 2026Mar 2029

First Submitted

Initial submission to the registry

January 30, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 6, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

April 10, 2026

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2029

Last Updated

April 15, 2026

Status Verified

April 1, 2026

Enrollment Period

3 years

First QC Date

January 30, 2026

Last Update Submit

April 10, 2026

Conditions

Keywords

geriatric oncologysocial networks

Outcome Measures

Primary Outcomes (1)

  • Study feasibility

    Retention rate. Percentage of patients who complete at least three SONATA sessions and week 16 post-intervention assessments

    From baseline to week 16

Secondary Outcomes (4)

  • Emotional, social, and existential quality of life

    From baseline to week 16

  • Patient Activation

    From baseline to week 16.

  • Autonomy, Competence, and Relatedness

    From baseline to week 16

  • Social Support

    From baseline to week 16

Study Arms (2)

SONATA Intervention

EXPERIMENTAL

Following randomization, patients assigned to SONATA will participate in up to six coaching sessions, delivered either in person or via Zoom over approximately six weeks.

Behavioral: SONATA

Enhanced Usual Care

NO INTERVENTION

Patients randomized to enhanced usual care will receive standard educational materials within 4 weeks of randomization.

Interventions

SONATABEHAVIORAL

SONATA includes six evidence-based components to help patients: 1) identify and set personal goals to achieve well-being (goal-setting); 2) identify their social network (SN) members and map their SNs (network diagnostics); 3) engage key SN members to address their goals and needs (network engagement); 4) build channels for communication and collaboration with key SN members via in-person and virtual activities (opportunity creation); 5) communicate effectively with their key SN members, develop action plans, and provide support (skill building); and 6) engage in cycles of feedback to effectively respond to the patient's evolving needs.

SONATA Intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥65 years
  • A diagnosis of advanced or likely incurable cancer, as determined by the primary oncologist
  • Able to speak English
  • Able to provide informed consent

You may not qualify if:

  • Any psychiatric or cognitive impairments interfering with participation as determined by the oncology team
  • Unwilling to complete study procedures
  • Social Network Members (if available, for intervention arm only)
  • Age ≥18 years
  • Identified as an SN member by the patient in the intervention arm
  • Able to speak English
  • Able to provide informed consent
  • Unwilling to complete study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester

Rochester, New York, 14642, United States

RECRUITING

Related Publications (2)

  • Kehoe L, Sanapala C, DiGiovanni G, Yousefi-Nooraie R, Yilmaz S, Bauer J, Loh KP, Norton S, Duberstein P, Kamen C, Gilmore N, Gudina A, Kleckner A, Mohile S, Epstein RM. Older adults with advanced cancer are selective in sharing and seeking information with social networks. Patient Educ Couns. 2022 Oct;105(10):3116-3122. doi: 10.1016/j.pec.2022.06.005. Epub 2022 Jun 9.

    PMID: 35717349BACKGROUND
  • Yu V, Yilmaz S, Freitag J, Loh KP, Kehoe L, Digiovanni G, Bauer J, Sanapala C, Epstein RM, Yousefi-Nooraie R, Mohile S. The role of social networks in prognostic understanding of older adults with advanced cancer. Patient Educ Couns. 2023 Jan;106:135-141. doi: 10.1016/j.pec.2022.10.009. Epub 2022 Oct 15.

    PMID: 36270857BACKGROUND

MeSH Terms

Interventions

zaleplon

Study Officials

  • Kah Poh Loh

    University of Rochester

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 30, 2026

First Posted

February 6, 2026

Study Start

April 10, 2026

Primary Completion (Estimated)

March 31, 2029

Study Completion (Estimated)

March 31, 2029

Last Updated

April 15, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Permission will also be asked on the consent form for the use of patient and social network (SN) data for future research not described in this consent. In addition, permission will be asked from patients and SN members to share de-identified transcripts from recordings for future research not described in the consent.

Shared Documents
STUDY PROTOCOL
Time Frame
All study data will be kept for a period of 7 years after the date of study closure.

Locations